Gene: PRXL2A
Official Full Name: peroxiredoxin like 2Aprovided by HGNC
Gene Summary: Enables antioxidant activity. Involved in regulation of osteoclast differentiation. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24963 | PRXL2A Knockout cell line (HeLa) | Human | PRXL2A | 1:3~1:6 | Negative | Online Inquiry |
KO24964 | PRXL2A Knockout cell line (HCT 116) | Human | PRXL2A | 1:2~1:4 | Negative | Online Inquiry |
KO24965 | PRXL2A Knockout cell line (HEK293) | Human | PRXL2A | 1:3~1:6 | Negative | Online Inquiry |
KO24966 | PRXL2A Knockout cell line (A549) | Human | PRXL2A | 1:3~1:4 | Negative | Online Inquiry |
PRXL2A Gene Knockout Cell Lines are advanced biological tools designed to facilitate the exploration of gene function and regulation, specifically targeting the PRXL2A gene, implicated in various physiological processes and disease states. These cell lines have been engineered to lack the PRXL2A gene, allowing researchers to study the consequences of its functional loss in a controlled environment. By providing a platform to analyze both the direct and downstream effects of PRXL2A ablation, these cell lines are invaluable for elucidating the gene’s role in cellular pathways and mechanisms.
The primary function of PRXL2A Gene Knockout Cell Lines lies in their ability to enable researchers to perform loss-of-function studies. This is achieved through the application of CRISPR-Cas9 gene editing technologies, which effectively disrupt the PRXL2A gene, allowing for the investigation of cellular responses such as changes in metabolic activity, signal transduction, and gene expression profiles. Researchers can utilize these knockout models to assess phenotypic alterations, offering insights into the gene's contribution to normal physiological processes and its potential involvement in pathologies such as cancer and metabolic disorders.
The scientific importance of PRXL2A Gene Knockout Cell Lines cannot be overstated; they are crucial in translational research, where understanding gene function may lead to the identification of novel therapeutic targets. In clinical settings, these models may assist in the development of personalized medicine approaches by revealing how variations in PRXL2A expression influence treatment responses.
One significant advantage of PRXL2A Gene Knockout Cell Lines is their specificity and reproducibility compared to alternative models, such as conventional knockout mice or non-targeted cell lines. They provide a faster, cost-effective means to generate results without the complexities associated with whole-organism studies. Moreover, the reliability of these cell lines fosters confidence in the data obtained, which is essential for high-throughput screening and validation.
Researchers and clinicians will find PRXL2A Gene Knockout Cell Lines to be a valuable addition to their toolkit, as they offer unique opportunities to dissect gene functions and their implications in health and disease. With expertise in producing high-quality biological products, our company is committed to advancing scientific research with innovative solutions, ensuring researchers have the resources necessary to drive discovery and development in their fields.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.